Professor Anderson says there are at least two companies trying different cell encapsulation strategies, in the same way that a tea bag surrounds the leaves of tea. The US federal government has given companies permission to begin patient trials starting later this year. [5] By protecting the immune system's beta cells, this would significantly speed up the availability of treatment for patients with type 1 diabetes and also eliminate the need for patients to undergo regular infusions of beta cells into their pancreas. Making this treatment a treatment with no further follow-up required, meaning it is essentially a cure..